Taysha Gene Therapies (TSHA) Earnings Date & Reports

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TSHA is expected to report earnings to rise 31.86% to -9 cents per share on May 07

Taysha Gene Therapies TSHA Stock Earnings Reports

Q1'25

Est.

$-0.09

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.07

Q1'24

Beat

by $0.01

The last earnings report on February 26 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 794.71K shares outstanding, the current market capitalization sits at 365.00M.

View a ticker or compare two or three

Compare

TSHA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TSHA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3000 Pegasus Park Drive

Phone

+1 214 612-0000

Employees

Web

https://www.tayshagtx.com